Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Review

Overview

abstract

Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. © 2016 International Parkinson and Movement Disorder Society.

authors

Strafella, Antonio P

Bohnen, Nicolaas I

Perlmutter, Joel S

Eidelberg, David M.
Pavese, Nicola
Van Eimeren, Thilo
Piccini, Paola
Politis, Marios
Thobois, Stephane
Ceravolo, Roberto
Higuchi, Makoto
Kaasinen, Valtteri
Masellis, Mario
Peralta, M Cecilia
Obeso, Ignacio
Pineda-Pardo, Jose Ángel
Cilia, Roberto
Ballanger, Benedicte
Niethammer, Martin
Stoessl, Jon A

publication date

February 2, 2017

published in

Movement disorders : official journal of the Movement Disorder Society Journal

Research

keywords

Molecular Imaging
Parkinson Disease
Parkinsonian Disorders

Identity

Scopus Document Identifier

85011698068

Digital Object Identifier (DOI)

10.1002/mds.26907

PubMed ID

28150432

Additional Document Info

has global citation frequency

75

volume

32

issue

2